Metyrapone
Back to searchMolecule Structure
Scientific Name
Metyrapone
Description of the Drug
Metyrapone is a steroid 11-beta-monooxygenase inhibitor used to test hypothalamic-pituitary ACTH function.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01011
http://www.drugbank.ca/drugs/DB01011
Brand Name(s)
Metopiron, Metopirone
Company Owner(s)
Hra Pharma Rare Diseases
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL637432 | |||
| PharmGKB | PA450486 | |||
| Human Metabolome Database | HMDB0015146 | |||
| DrugBank | DB01011 | |||
| PubChem: Thomson Pharma | 14749227 | |||
| PubChem | 4174 | |||
| Mcule | MCULE-7018205003 | |||
| LINCS | LSM-3035 | |||
| Nikkaji | J1.369B | |||
| PDBe | MYT | |||
| BindingDB | 50028166 | |||
| EPA CompTox Dashboard | DTXSID1023314 | |||
| DrugCentral | 1791 | |||
| Brenda | 172767 | 29237 | 91097 | 990 |
| ChemicalBook | CB8329426 | |||
| Guide to Pharmacology | 5224 | |||
| rxnorm | METOPIRONE | METYRAPONE TARTRATE | METYRAPONE | |
| KEGG Ligand | C07205 | |||
| ChEBI | 44241 | |||
| ZINC | ZINC000000001728 |
